ACASTI PHARMA INC (ACST)
CA00430K8656 - Common Stock
| TTM (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.78M | -42.43M | -9.82M | -19.68M | -25.51M | |||
| Depreciation Amortization | 10.00K | 120.00K | 0.00 | 920.00K | 2.32M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.63M | 180.00K | -2.79M | -5.95M | -3.22M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 26.82M | 26.21M | -4.63M | 10.38M | 3.46M | |||
| OPERATING CASH FLOW | -13.56M | -15.91M | -17.23M | -14.32M | -22.95M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -10.00K | -20.00K | 0.00 | -70.00K | -320.00K | |||
| Other Investing Activity | -1.44M | 13.17M | -3.52M | -9.79M | 8.46M | |||
| INVESTING CASH FLOW | -1.45M | 13.15M | -3.52M | -9.86M | 8.14M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | -1.56M | |||
| Stock Issued/Repurchased | 7.36M | 300.00K | 0.00 | 59.63M | 14.73M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -140.00K | 10.00K | |||
| FINANCING CASH FLOW | 7.36M | 300.00K | 0.00 | 59.49M | 13.18M | |||
| Exchange Rate Effect | -30.00K | -10.00K | 150.00K | 1.39M | -1.00M | |||
| CHANGE IN CASH | -7.69M | -2.47M | -20.60M | 36.70M | -2.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.56M | -15.91M | -17.23M | -14.32M | -22.95M | |||
| Capital Expenditure | -10.00K | -20.00K | 0.00 | -70.00K | -320.00K | |||
| FREE CASH FLOW | -13.57M | -15.93M | -17.23M | -14.39M | -23.27M | |||
All data in USD